Skip to main content

and
  1. No Access

    Article

    Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma

    Studies on the biologic and molecular genetic underpinnings of multiple myeloma (MM) have identified the pleiotropic, pro-inflammatory cytokine, interleukin-6 (IL-6), as a factor crucial to the growth, prolife...

    Timothy R. Rosean, Van S. Tompkins, Guido Tricot, Carol J. Holman in Immunologic Research (2014)